Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Patent
1994-09-30
1998-05-12
Feisee, Lila
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
4241851, 42419511, 424573, 514 21, A61K 3900, A61K 39385, A61K 3512, A61K 3800
Patent
active
057501190
ABSTRACT:
Disclosed is a method for inhibiting the proliferation of a tumor in a mammal. The method involves the steps of (a) isolating a stress protein-peptide complex from tumor cells previously removed from the mammal and (b) administering the isolated stress protein-peptide complex back to the mammal in order to stimulate in the mammal an immune response against the tumor from which the complex was isolated. Stress protein-peptide complexes having particular utility in the practice of the instant invention include the Hsp70-peptide, Hsp90-peptide and gp96-peptide complexes.
REFERENCES:
patent: 5188964 (1993-02-01), McGuire et al.
patent: 5232833 (1993-08-01), Sanders et al.
patent: 5288639 (1994-02-01), Burnie et al.
patent: 5348945 (1994-09-01), Berberian et al.
Srivastava et al. (Mar. 1993) "Evidence for peptide-chaperoning by the enlasmic reticular heat shock protein GP96: Implications for vaccination against cancer and infectious diseases", J Cell Biochem Suppl 17D:94 (Abstract NZ 014).
Thomas et al. (1982) "Molecular and Cellular Effects of Heat-Shock and Related Treatments of Mammalian Tissue-Culture Cells" Cold Spring Harbor Quant Biol, 46:985-996.
Welch et al. (1982) "Purification of the Major Mammalian Heat Shock Proteins", J Biol Chem 357:14949-14959.
Levinson et al. (1979) "Metal Binding Drugs Induce Synthesis of Four Proteins in Normal Cells", Biological Trace Element Research 1:15-23.
Blachere et al. (1993) "Immunization with GP96 Heat Shock Proteins Isolated from Tumors or Influenza Virus Infected Cells Elicits MHC--Restricted, Antigen--Specific Cytotoxic T Lymphocytes Against the Corresponding Cells/Antigens" Abstract presented by the UCLA Symposium, Taos, New Mexico, Mar. 17-24, 1993, Cellular Immunity and the Immunotherapy of Cancer, J. Cellular Biochem. 17D:124.
Blachere et al. (1993) "Heat Shock Protein Vaccines Against Cancer", Journal of Immunotherapy 14:352-356.
Franklin, C. (Nov. 1993) "Making Vaccines Fit the Cancer" New Scientist, vol. 140, p. 17.
Lukacs et al. (1993) "Tumor Cells Transfected with a Bacterial Heat-Shock Gene Lose Tumorigenicity and Induce Protection against Tumors", J. Exp. Med. 178:343-348.
Palladino, Jr., et al. (1987) "Expression of a Shared Tumor-specific Antigen by Two Chemically Induced BALB/c Sarcomas.sup.1 ", Cancer Research 47:5074-5079.
Srivastava et al. (1986) "Tumor Rejection Antigens of Chemically Induced Sarcomas of Inbred Mice", Proc. Natl. Acad. Sci. USA 83:3407-3411.
Srivastava et al. (1988) "Individually Distinct Transplantation Antigens of Chemically Induced Mouse", Immunology Today 9:78-83.
Srivastava et al. (1991) "Stress-Induced Proteins in Immune Response to Cancer", Current Topics in Microbiology and Immunology 167:109-123.
Srivastava, P.K. (1991) "Protein Tumor Antigens" Current Opinion in Immunology, Cancer 3:654-658.
Li et al. (1993) "Tumor Rejection Antigen gp96/grp94 is an ATPase: Implications for Protein Folding and Antigen Presentation" The EMBO Journal 12:3143-3151.
Srivastava et al. (1991) "Tumor-specific Immunogenicity of Stress-induced Proteins: Convergence of Two Evolutionary Pathways of Antigen Presentation?", Immunology 2:00-00.
Srivastava et al. (1993) "Peptide-Binding Heat Shock Proteins in the Endoplasmic Reticulum: Role in Immune Response to Cancer and in Antigen Presentation", Advances in Cancer Research 62:153-177.
Srivastava et al. (1994) "Heat Shock Proteins Transfer Peptides During Antigen Processing and CTL Priming", Immunogenetics 39:93-98.
Udono et al. (1994) "Cellular Requirements for Tumor-Specific Immunity Elicited by Heat Shock Proteins: Tumor Rejection Antigen gp96 Primes Naive CD8+ T cells In Vivo", Proc. Natl. Acad. Sci. USA 91:3077-3081.
Udono et al. (1993) "Heat Shock Protein 70-associated Peptides Elicit Specific Cancer Immunity", J. Exp. Med. 178:1391-1396.
Vogue (Mar. 1994) Health News p. 258.
Aldovini et al. (1992) "The New Vaccines", Technology Review pp. 24-31.
Barrios et al. (1992) "Mycobacterial Heat-Shock Proteins as Carrier Molecules. II: The Use of the 70-kDa Mycobacterial Heat-shock Protein as Carrier for Conjugated Vaccines can Circumvent the need for Adjuvants and Bacillus Calmette Guerin Priming", Eur. J. Immunol. 22:1365-1372.
Basombrio (1970) "Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene", The Institute for Cancer Resarch 30:2458-2462.
Bensaude et al. (1983) "Spontaneous high expression of heat-shock proteins in mouse embryonal carcinoma cells and ectoderm from day 8 mouse embryo", EMBO J. 2:173-177.
Boon (1992) "Toward a genetic analysis of tumor rejection antigens", Advances in Cancer Research 58:177-210.
Cohen (1993) "Cancer vaccines get a shot in the arm", Science 262:841-843.
Craig (1993) "Chaperones: Helpers Along the Pathways to Protein Folding", Science 260:1902-1904.
Ebert, (1987) "Characterization of an immunosuppressive factor derived from colon cancer cells", J. Immunol., 138(7):2161-2168.
Elliott et al. (1990) "Naturally Processed Peptides", Nature 348:195-197.
Falk et al. (1990) "Cellular Peptide Composition Governed by Major Histocompatibility Complex Class I Molecules", Nature 348:248-251.
Falk et al. (1991) "Allele-specific Motifs Revealed by Sequencing of Self-peptides Eluted from MHC Molecules", Nature 351:290-296.
Feldweg et al. (1993) "Evidence for biochemical heterogeneity of gp96 heat shock protein/tumor rejection antigen", J. Cell. Biochem. Suppl. 17D:108 (abstract).
Flynn et al. (1989) "Peptide binding and release by proteins implicated as catalysts of protein assembly", Science 245:385-390.
Flynn et al. (1991) "Peptide-binding Specificity of the Molecular Chaperone BiP", Nature 353:726-730.
Gething et al. (1992) "Protein Folding in the Cell", Nature 355:33-45.
Globerson and Feldman (1964) "Antigenic Specificity of
Heike et al. (1994) "Protective cellular immunity against a spontaneous mammary carcinoma from ras transgenic mice", Immunobiology 190(4-5):411-423.
Huber et al. (1982) "Protease inhibitors interfere with the transforming growth factor-.beta.-dependent but not the transforming growth factor-.beta.-independent pathway of tumor cell-mediated immunosuppression", J. Immunol. 148(1):277-284.
Jakob et al. (1993) "Small Heat Shock Proteins Are Molecular Chaperones", J. Biol. Chem. 268:1517-1520.
Jardetzky et al. (1991) "Identification of Self Peptides Bound to Purified HLA-B27", Nature 353:326-329.
Lakey et al. (1987) "Identification of a peptide binding protein that plays a role in antigen presentation", Proc. Natl. Acad. Sci. USA 84:1659-1663.
Lanzavecchia (1993) "Identifying Strategies for Immune Intervention", Science 260:937-944.
Levy (1991) "ATP is Required for In Vitro Assembly of MHC Class I Antigens but Not for Transfer of Peptides across the ER Membrane", Cell 67:265-274.
Li et al. (1994) "A critical contemplation on the role of heat shock proteins in transfer of antigenic peptides during antigen presentation", Behring Institute Mitteilungen 94:37-47.
Lindquist et al. (1988) "The Heat-Shock Proteins", Annu. Rev. Genet. 22:631-677.
Luescher et al. (1991) "Specific Binding of Antigenic Peptides to Cell-associated MHC Clas I Molecules", Nature 351:72-77.
Lussow et al. (1991) "Mycobacterial Heat-Shock Proteins as Carrier Molecules", Eur. J. Immunol. 21:2297-2302.
Madden et al. (1991) "The Structure of HLA-B27 Reveals Nonamer Self-peptides Bound in an Extended Conformation", Nature 353:321-325.
Maki et al. (1990) "Human homologue of murine tumor rejection antigen gp96: 5'-Regulatory and coding regions and relationship to stress-induced proteins", Proc. Natl. Acad. Sci. USA 87:5658-5663.
Maki et al. (1993) "Mapping of the Genes for Human Endoplasmic Reticular Heat Shock Protein gp96/grp94", Somatic Cell Mol. Genetics 19(1):73-81.
McCall et al. (1989) "Biotherapy: A New Dimension in Cancer Treatment", Biotechnology 7:231-240.
Melnick (1985) "Virus Vaccines: An Overview", Proceedings of the First Annual Southwest Foundation for Biomedical Research International Symposium, Houston, Texas, 8-10 Nov. 1984, American Society for Microbiology pp. 1-13.
Mizoguchi et al. (1982) "Alterations in signa
Bansal Geetha P.
Feisee Lila
Mount Sinai School of Medicine Of The City University of New Yor
LandOfFree
Immunotherapeutic stress protein-peptide complexes against cance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapeutic stress protein-peptide complexes against cance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic stress protein-peptide complexes against cance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-976939